两亲性嵌段共聚物递送寨卡病毒DNA疫苗
该研究在 mice 中测试了由四功能两亲性嵌段共聚物(ABC)递送的寨卡病毒 prM-E DNA 疫苗;单次接种低剂量(10 µg)质粒可在首次接种超过 7 个月、攻击前 2 周加强后快速诱导针对三种不同寨卡分离株的抗体滴度与中和活性,并防止急性感染期可检测病毒血症。
要点
- 四功能 ABC 递送 prM-E DNA 在测试的抗原设计中诱导最高抗体滴度和针对三种不同寨卡分离株的中和活性。
- 单次接种低剂量(10 µg)DNA 质粒可在 mice 中快速诱导保护,防止急性感染期可检测病毒血症。
- 保护在首次接种超过 7 个月、攻击前 2 周加强后仍可见。
核心结论
- 四功能 ABC 递送 DNA 抗原是针对黄病毒的新方法,可快速诱导针对多种不同寨卡病毒分离株的保护性应答。
研究设计与样本
- 在 mice 中测试四功能两亲性嵌段共聚物(ABC)递送编码 prM-E 全长天然序列的 DNA 疫苗,并与其它抗原设计比较。
主要发现
- 在测试的抗原设计中,四功能 ABC 递送 prM-E DNA 诱导最高抗体滴度和针对三种不同寨卡病毒分离株的中和活性。
- 单次四功能 ABC 递送低剂量(10 µg)DNA 质粒可在首次接种超过 7 个月、攻击前 2 周加强后快速诱导保护,防止急性感染期可检测病毒血症。
关键数值与推荐
- 低剂量 DNA 质粒为 10 µg。
- 攻击在首次接种超过 7 个月后进行,并于攻击前 2 周加强。
临床怎么用
- 原文未报告临床实践应用。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Zika virus (ZIKV) is a mosquito-borne flavivirus that was first discovered in 1947. Since then, outbreaks have been reported in tropical Africa, Southeast Asia, the Pacific Islands, and, in 2015, in the Americas. Since 2013, many countries have reported cases of microcephaly and other central nervous system malformation associated with ZIKV. Because the initial target population for a ZIKV vaccine is expected to be women of child-bearing age, including those who may be pregnant, it is necessary to develop safe, easily administered, and non-viral vaccines. Here, we show that a single tetrafunctional Amphiphilic Block Copolymer (ABC) delivers DNA that encodes the full natural sequence of prM-E, among other antigen designs tested, induces the highest antibody titer and neutralization activity against three divergent ZIKV isolates. Vaccination with a single tetrafunctional block copolymer delivering low dose (10 µg) DNA plasmid rapidly induces protection from detectable viremia during acute infection in mice challenged by ZIKV more than 7 months after their first vaccination and boosted 2 weeks before challenge. This use of tetrafunctional ABCs is a new approach to deliver DNA antigens against flaviviruses. The data demonstrate that DNA formulated by a tetrafunctional block copolymer rapidly elicits protective responses against multiple diverse ZIKV isolates. This represents potential for an easy-to-administer and simple to manufacture vaccine candidate against ZIKV and possibly other emerging threats to global health.
引用
- Hraber P, Bradfute S, Clarke E, et al. Amphiphilic block copolymer delivery of a DNA vaccine against Zika virus. Vaccine. 2018. PMID: 30337177. doi:10.1016/j.vaccine.2018.10.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。